Human infection (or challenge) studies involve the intentional administration of a pathogen (challenge agent) to volunteers.
A Perspectives piece on how WHO recommendations were implemented to set up the world's first human challenge study with SARS-CoV-2.
Streptococcus pyogenes is a leading cause of infection-related morbidity and mortality.
The UK will be the first country to run a Covid-19 human infection challenge study, following a favourable opinion from the UK’s clinical trials ethics body.
The bacterial pathogen Salmonella Typhi causes typhoid fever, which is a global health problem.
Professor Peter Openshaw has recorded a MOOC Vaccinology session, and describes how human challenge studies are accelerating vaccine development.
Five research teams are each receiving around £100,000 of seed-funding to help set up or improve human infection studies to better understand diseases, how they spread and develop ways to prevent or treat them.
Guiding principles for researchers applying for funding for human infection studies could help to invigorate the field, according to a new report published by the Academy of Medical Sciences today (July 25, 2018).
Nine research teams are each receiving around £100,000 of seed-funding to help set up or improve volunteer infection studies for a range of different diseases.
Over the weekend of 28-29 April, Imperial College opened its gates to welcome children and their families to the Imperial Festival.
This meeting, held on 6 February 2018 and hosted by the Academy of Medical Sciences and funded by HIC-Vac, the MRC and Wellcome Trust, was a fantastic opportunity for the research community to come together and discuss the regulatory and ethical c